{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:39:03Z","timestamp":1792539543316,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82441052"],"award-info":[{"award-number":["82441052"]}]},{"name":"National Natural Science Foundation of China","award":["82441055"],"award-info":[{"award-number":["82441055"]}]},{"name":"Shenzhen Key Laboratory of Viral Vectors for Biomedicine","award":["ZDSYS20200811142401005"],"award-info":[{"award-number":["ZDSYS20200811142401005"]}]},{"name":"Brain Science and Brain-like Intelligence Technology-National Science and Technology Major Project","award":["2021ZD0201003"],"award-info":[{"award-number":["2021ZD0201003"]}]},{"name":"Guangdong Provincial Key Laboratory of Viral Biotechnology and Application","award":["2022KSYS012"],"award-info":[{"award-number":["2022KSYS012"]}]},{"name":"Shenzhen Science and Technology Major Project","award":["KJZD20230923114307015"],"award-info":[{"award-number":["KJZD20230923114307015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dual adeno-associated virus (AAV) vector reconstitution has become an indispensable technique for delivering large genes in neuroscience and gene therapy. A novel technology termed StitchR addresses the challenge of low efficiency in dual-AAV reconstruction, yet related tools enabling targeted gene delivery to specific neural cell populations remain insufficiently developed. Herein, we developed four StitchR-based dual-viral reconstitution strategies by combining high-efficiency AAV serotypes with neuron- or glia-specific promoters. Specifically, the AAV11-hSyn-driven StitchR strategy achieved specific transduction of local neurons and their upstream projection neurons (\u2265\u200994.44% specificity); the AAV11-GfaABC1D-driven strategy realized astrocyte-specific transduction (approximately 98.25% specificity); and the AAV11-mIBA1-driven strategy enabled microglia-specific transduction (100% specificity). Furthermore, by incorporating the blood\u2013brain barrier (BBB)-penetrating AAVhu.32-PLUS into the hSyn-driven system, we established a modified strategy that allows brain-wide neuronal transduction. Finally, we confirmed that the StitchR-based dual-viral reconstitution strategy can achieve efficient functional reconstitution of large transgenes in neural cells. Collectively, these dual-AAV delivery strategies expand the valuable AAV toolbox and offer crucial technical support for targeted delivery of large transgenes to defined neural cell populations, holding great significance for basic neuroscience research and potential therapeutic applications.<\/jats:p>","DOI":"10.1186\/s13041-026-01331-0","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:25:23Z","timestamp":1784892323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["StitchR-based dual-AAV delivery strategies enable efficient transduction of defined neural cell populations"],"prefix":"10.1186","volume":"19","author":[{"given":"Nengsong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengpeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunzhang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"1331_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102414","volume":"100","author":"OF Sultana","year":"2024","unstructured":"Sultana OF, Bandaru M, Islam MA, Reddy PH. Unraveling the complexity of human brain: structure, function in healthy and disease states. Ageing Res Rev. 2024;100:102414.","journal-title":"Ageing Res Rev"},{"key":"1331_CR2","doi-asserted-by":"crossref","unstructured":"Yang A, Yang A, Shu J, Wu X, Zhu Z. Extracellular vesicles combined with hyperbaric oxygen therapy as new strategies for the treatment of traumatic brain injury: a narrative review. Adv Technol Neurosci. 2025;2:187\u2013203.","DOI":"10.4103\/ATN.ATN-D-25-00012"},{"key":"1331_CR3","doi-asserted-by":"crossref","unstructured":"Chen Z, Shi J, Li L. Application of single-cell sequencing technology and its clinical implications in Parkinson\u2019s disease and Alzheimer\u2019s disease: a narrative review. Adv Technol Neurosci. 2025;2:9\u201315.","DOI":"10.4103\/ATN.ATN-D-24-00015"},{"key":"1331_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nbt.3055","volume":"33","author":"L Swiech","year":"2015","unstructured":"Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y, Trombetta J, et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol. 2015;33:102\u20136.","journal-title":"Nat Biotechnol"},{"key":"1331_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","volume":"3","author":"E Alton","year":"2015","unstructured":"Alton E, Armstrong DK, Ashby D, Bayfield KJ, Bilton D, Bloomfield EV, et al. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med. 2015;3:684\u201391.","journal-title":"Lancet Respir Med"},{"key":"1331_CR6","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713\u201322.","journal-title":"N Engl J Med"},{"key":"1331_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"1331_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","volume":"20","author":"DA Kuzmin","year":"2021","unstructured":"Kuzmin DA, Shutova MV, Johnston NR, Smith OP, Fedorin VV, Kukushkin YS, et al. The clinical landscape for AAV gene therapies. Nat Rev Drug Discov. 2021;20:173\u20134.","journal-title":"Nat Rev Drug Discov"},{"key":"1331_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101400","volume":"105","author":"H Ge","year":"2025","unstructured":"Ge H, Shi Z, Liu C, Lu J, Yao Y, Cheng B. Viral and non-viral vectors for gene therapy in the treatment of bone-related disorders: molecular insights and clinical perspectives. Mol Aspects Med. 2025;105:101400.","journal-title":"Mol Aspects Med"},{"key":"1331_CR10","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1126\/science.adp8179","volume":"386","author":"SR Lindley","year":"2024","unstructured":"Lindley SR, Subbaiah KCV, Priyanka F, Poosala P, Ma Y, Jalinous L, et al. Ribozyme-activated mRNA trans-ligation enables large gene delivery to treat muscular dystrophies. Science. 2024;386:762\u20137.","journal-title":"Science"},{"key":"1331_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39554-7","volume":"14","author":"Z Han","year":"2023","unstructured":"Han Z, Luo N, Ma W, Liu X, Cai Y, Kou J, et al. AAV11 enables efficient retrograde targeting of projection neurons and enhances astrocyte-directed transduction. Nat Commun. 2023;14:3792.","journal-title":"Nat Commun"},{"key":"1331_CR12","doi-asserted-by":"publisher","unstructured":"Luo N, Lin K, Cai Y, Sui X, Zhang Z, Xing J, et al. Microglia-specific transduction via AAV11 armed with IBA1 promoter and miRNA-9 targeting sequences. bioRxiv 2024. https:\/\/doi.org\/10.1101\/2024.07.09.602653","DOI":"10.1101\/2024.07.09.602653"},{"key":"1331_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jconrel.2025.01.021","volume":"379","author":"N Luo","year":"2025","unstructured":"Luo N, Lin K, Cai Y, Zhang Z, Sui X, Han Z, et al. An engineered adeno-associated virus mediates efficient blood-brain barrier penetration with enhanced neurotropism and reduced hepatotropism. J Control Release. 2025;379:303\u201315.","journal-title":"J Control Release"},{"key":"1331_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn5603","volume":"17","author":"JK Mich","year":"2025","unstructured":"Mich JK, Ryu J, Wei AD, Gore BB, Guo R, Bard AM, et al. Interneuron-specific dual-AAV SCN1A gene replacement corrects epileptic phenotypes in mouse models of Dravet syndrome. Sci Transl Med. 2025;17:eadn5603.","journal-title":"Sci Transl Med"},{"key":"1331_CR15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gt.2017.71","volume":"24","author":"J Miniarikova","year":"2017","unstructured":"Miniarikova J, Zimmer V, Martier R, Brouwers C, Pythoud C, Richetin K, et al. AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington\u2019s disease. Gene Ther. 2017;24:630\u20139.","journal-title":"Gene Ther"},{"key":"1331_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12311-018-0917-6","volume":"17","author":"P Pastor","year":"2018","unstructured":"Pastor P, Du X, Fazal S, Davies A, Gomez C. Targeting the CACNA1A IRES as a treatment for spinocerebellar ataxia type 6. Cerebellum. 2018;17:72\u20137.","journal-title":"Cerebellum"},{"key":"1331_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41587-023-01758-z","volume":"42","author":"JR Davis","year":"2024","unstructured":"Davis JR, Banskota S, Levy JM, Newby GA, Wang X, Anzalone AV, et al. Efficient prime editing in mouse brain, liver and heart with dual AAVs. Nat Biotechnol. 2024;42:253\u201364.","journal-title":"Nat Biotechnol"},{"key":"1331_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114797","volume":"14","author":"J Giehrl-Schwab","year":"2022","unstructured":"Giehrl-Schwab J, Giesert F, Rauser B, Lao C, Hembach S, Lefort S, et al. Parkinson\u2019s disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons. EMBO Mol Med. 2022;14:e14797.","journal-title":"EMBO Mol Med"},{"key":"1331_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19:622\u201335.","journal-title":"Nat Rev Neurosci"},{"key":"1331_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4103\/1673-5374.322423","volume":"17","author":"J Cornell","year":"2022","unstructured":"Cornell J, Salinas S, Huang HY, Zhou M. Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res. 2022;17:705\u201316.","journal-title":"Neural Regen Res"},{"key":"1331_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-023-06713-1","volume":"623","author":"DS Park","year":"2023","unstructured":"Park DS, Kozaki T, Tiwari SK, Moreira M, Khalilnezhad A, Torta F, et al. iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer. Nature. 2023;623:397\u2013405.","journal-title":"Nature"},{"key":"1331_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a023622","author":"WW Seeley","year":"2017","unstructured":"Seeley WW. Mapping neurodegenerative disease onset and progression. Cold Spring Harb Perspect Biol. 2017. https:\/\/doi.org\/10.1101\/cshperspect.a023622.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1331_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2009.03.024","volume":"62","author":"WW Seeley","year":"2009","unstructured":"Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron. 2009;62:42\u201352.","journal-title":"Neuron"},{"key":"1331_CR24","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nature05289","volume":"443","author":"JJ Palop","year":"2006","unstructured":"Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature. 2006;443:768\u201373.","journal-title":"Nature"},{"key":"1331_CR25","doi-asserted-by":"publisher","first-page":"18760","DOI":"10.1073\/pnas.0708803104","volume":"104","author":"C Sorg","year":"2007","unstructured":"Sorg C, Riedl V, M\u00fchlau M, Calhoun VD, Eichele T, L\u00e4er L, et al. Selective changes of resting-state networks in individuals at risk for Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2007;104:18760\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1331_CR26","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41591-024-03466-w","volume":"31","author":"M An","year":"2025","unstructured":"An M, Davis JR, Levy JM, Serack FE, Harvey JW, Brauer PP, et al. In vivo base editing extends lifespan of a humanized mouse model of prion disease. Nat Med. 2025;31:1319\u201328.","journal-title":"Nat Med"},{"key":"1331_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1607","volume":"14","author":"V Kolesnik","year":"2024","unstructured":"Kolesnik V, Nurtdinov R, Oloruntimehin S, Karabelsky A, Malogolovkin AS. Optimization strategies and advances in the research and development of AAV-based gene therapy to deliver large transgenes. Clin Transl Med. 2024;14:e1607.","journal-title":"Clin Transl Med"},{"key":"1331_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/hum.2019.220","volume":"31","author":"P Tornabene","year":"2020","unstructured":"Tornabene P, Trapani I. Can adeno-associated viral vectors deliver effectively large genes? Hum Gene Ther. 2020;31:47\u201356.","journal-title":"Hum Gene Ther"},{"key":"1331_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1006\/mcne.2000.0929","volume":"17","author":"S K\u00fcgler","year":"2001","unstructured":"K\u00fcgler S, Meyn L, Holzm\u00fcller H, Gerhardt E, Isenmann S, Schulz J, et al. Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors. Mol Cell Neurosci. 2001;17:78\u201396.","journal-title":"Mol Cell Neurosci"},{"key":"1331_CR30","doi-asserted-by":"crossref","unstructured":"Han Z, Luo N, Wu Y, Kou J, Ma W, Yang X, et al. AAV13 enables precise targeting of local neural populations. Int J Mol Sci. 2022;23:12806.","DOI":"10.3390\/ijms232112806"},{"key":"1331_CR31","first-page":"781","volume":"45","author":"N Luo","year":"2024","unstructured":"Luo N, Cai Y, Han Z, Sui X, Yuan W, Zhang Z, et al. Engineered AAV13 variants with enhanced transduction and confined spread. Zool Res. 2024;45:781\u201390.","journal-title":"Zool Res"},{"key":"1331_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"BE Deverman","year":"2016","unstructured":"Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A, et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol. 2016;34:204\u20139.","journal-title":"Nat Biotechnol"},{"key":"1331_CR33","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41592-022-01547-7","volume":"19","author":"R Lin","year":"2022","unstructured":"Lin R, Zhou Y, Yan T, Wang R, Li H, Wu Z, et al. Directed evolution of adeno-associated virus for efficient gene delivery to microglia. Nat Methods. 2022;19:976\u201385.","journal-title":"Nat Methods"},{"key":"1331_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50555-y","volume":"15","author":"F-E Eid","year":"2024","unstructured":"Eid F-E, Chen AT, Chan KY, Huang Q, Zheng Q, Tobey IG, et al. Systematic multi-trait AAV capsid engineering for efficient gene delivery. Nat Commun. 2024;15:6602.","journal-title":"Nat Commun"},{"key":"1331_CR35","doi-asserted-by":"crossref","unstructured":"Han Z, Luo N, Wang F, Cai Y, Yang X, Feng W, et al. Computer-aided directed evolution generates novel AAV variants with high transduction efficiency. Viruses. 2023;15:848.","DOI":"10.3390\/v15040848"},{"key":"1331_CR36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.aaw2900","volume":"366","author":"PJ Ogden","year":"2019","unstructured":"Ogden PJ, Kelsic ED, Sinai S, Church GM. Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design. Science. 2019;366:1139\u201343.","journal-title":"Science"},{"key":"1331_CR37","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.ymthe.2024.04.003","volume":"32","author":"X Ding","year":"2024","unstructured":"Ding X, Chen X, Sullivan EE, Shay T, Gradinaru V. Fast, accurate ranking of engineered proteins by target-binding propensity using structure modeling. Mol Ther. 2024;32:1687\u2013700.","journal-title":"Mol Ther"},{"key":"1331_CR38","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1016\/j.cell.2025.05.002","volume":"188","author":"Y Ben-Simon","year":"2025","unstructured":"Ben-Simon Y, Hooper M, Narayan S, Daigle TL, Dwivedi D, Way SW, et al. A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types. Cell. 2025;188:3045-3064.e3023.","journal-title":"Cell"},{"key":"1331_CR39","volume-title":"Paxinos and Franklin's the mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2012","unstructured":"Paxinos G, Franklin K. Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates. Amsterdam: Elsevier\/Academic Press; 2012."},{"key":"1331_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00679-1","volume":"13","author":"K Lin","year":"2020","unstructured":"Lin K, Zhong X, Li L, Ying M, Yang T, Zhang Z, et al. AAV9-Retro mediates efficient transduction with axon terminal absorption and blood-brain barrier transportation. Mol Brain. 2020;13:138.","journal-title":"Mol Brain"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-026-01331-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01331-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01331-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:54:59Z","timestamp":1792536899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-026-01331-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1186\/s13041-026-01331-0","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were approved by the Animal Care and Use Committee of the Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences (approval No. APM20026A).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"74"}}